Longeveron (LGVN) Interest Coverage Ratio Growth (5y) (2025 - 2026)

Longeveron (LGVN) Interest Coverage Ratio Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,290.43 Bn	66,290.15 Bn	-
2	Nanobiotix	1,914.07 Bn	1,914.01 Bn	-
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-
4	BeOne Medicines	467.97 Bn	463.18 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.73 Bn	115.48 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.42 Bn	61.67 Bn	3.31 Bn
7	Belite Bio	62.82 Bn	62.82 Bn	-
8	Argenx Se	56.00 Bn	50.82 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.51 Bn	34.50 Bn	959.66 Mn
10	Longeveron	15.30 Bn	15.28 Bn	264,000.00

Download Data